fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Procter & Gamble Health Ltd

Procter Gamble Health Ltd

Updated on August 9, 2020

Stock/Share Code - PGHL

Merck Limited is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments.

Below is the details of PGHL Procter Gamble Health Ltd

Market Cap₹6,823 Cr.
Current Price ₹4,684.7 as on 14 Aug 20
52 Week High / Low Price₹5,120.8 / ₹2,891.45
Face Value₹10
Stock P/E41.48
Book Value₹492.07
Dividend Yield0.58 %
ROCE78.16 %
ROE73.25 %
Sales Growth (3yrs)-3.32 %
SectorPharmaceuticals
IndustryPharmaceuticals - Multinational
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has good consistent profit growth of 71.59% over 5 years Company has a good return on equity (ROE) track record: 3 Years ROE 40.36% Company has been maintaining a healthy dividend payout of 45.56% Debtor days have improved from 43.98 to 28.45 days.
Cons: Stock is trading at 8.35 times its book value The company has delivered a poor growth of 1.25% over past five years.

Procter Gamble Health Ltd Price Chart

Procter Gamble Health Ltd Price Chart

Procter Gamble Health Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Abbott India ₹268.6 59.71 ₹35,537.23 Cr. 0.30 ₹186.69 Cr. 59.50 13.78 1078.25 37.36
2. Glaxosmi. Pharma ₹48.95 55.82 ₹23,197.62 Cr. 1.46 ₹138.07 Cr. -2.34 3.33 775.80 31.11
3. Pfizer ₹4,484.95 35.83 ₹18,475.68 Cr. 0.56 ₹139.06 Cr. 5.40 4.75 538.18 23.22
4. Sanofi India ₹8,321.35 37.29 ₹17,808.18 Cr. 1.37 ₹85.4 Cr. 24.62 9.37 784.50 28.84
5. Astrazeneca Phar ₹3,323.25 105.68 ₹7,632.5 Cr. 0.03 ₹9.58 Cr. -2.44 2.42 194.90 26.51
6. Proc. Gam. Heal. ₹126.8 41.48 ₹6,823.18 Cr. 0.58 ₹46.46 Cr. 14.12 -1.26 228.11 78.16
7. Novartis India ₹268.6 62.00 ₹1,415.4 Cr. 1.74 ₹7.73 Cr. -39.94 -13.39 117.46 7.58

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Procter Gamble Health Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020
Sales -165206179198220226204231234225237228
YOY Sales Growth %-37.96%-23.54%-28.53%-13.44%33.28%9.86%14.47%16.58%6.06%-0.43%15.84%-1.26%
Expenses -150169174174169168189181179175188169
Material Cost %35.78%37.87%27.92%32.03%31.30%31.15%32.54%34.68%26.36%34.62%33.88%35.15%
Employee Cost %15.15%13.97%15.71%15.24%15.38%12.78%18.74%13.11%14.31%13.44%12.77%10.15%
Operating Profit15374245158155055504959
OPM %9%18%2%12%23%26%8%22%23%22%21%26%
Other Income13163820211770918177610
Interest000000000000
Depreciation555754545444
Profit before tax2348373767717206367535165
Tax %13%34%26%38%28%26%1%36%35%32%25%28%
Net Profit2032272348527154144363846
EPS in Rs12.1219.0916.4313.6829.1031.53430.9424.5226.5621.5423.0227.99
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018TTM
Sales -313387473509590687798867940993698849924
Sales Growth %-4.72%23.96%22.11%7.60%15.81%16.57%16.08%8.74%8.30%5.65%-29.66%21.61%
Expenses -246338412450503582721809855877621701711
Material Cost %40.47%41.29%43.56%40.83%41.18%43.51%45.50%46.16%46.33%41.46%33.94%31.73%
Manufacturing Cost %6.27%6.51%6.54%6.06%6.99%5.50%7.76%7.46%6.64%5.91%9.36%8.11%
Employee Cost %10.65%12.35%12.07%13.46%13.77%12.42%12.66%13.10%13.15%15.55%15.75%15.47%
Other Cost %21.19%27.01%24.99%27.96%23.34%23.22%24.42%26.48%24.87%25.42%29.93%27.24%
Operating Profit675061608710677598511677148212
OPM %21%13%13%12%15%15%10%7%9%12%11%17%23%
Other Income404843431720212022247476841
Interest0000000000000
Depreciation76878910132325192117
Profit before tax10092969696117886783115132895236
Tax %31%31%32%34%33%33%37%35%36%31%29%6%
Net Profit6963656364785643547994839165
EPS in Rs36.0522.2838.3646.8332.2224.8430.7447.6756.57505.2599.11
Dividend Payout %49%47%51%250%0%5%25%23%23%23%27%87%

Compounded Sales Growth

  • 10 Years:: 8.16%
  • 5 Years:: 1.25%
  • 3 Years:: -3.32%
  • TTM:: 4.74%

Compounded Profit Growth

  • 10 Years:: 29.53%
  • 5 Years:: 71.59%
  • 3 Years:: 148.36%
  • TTM:: -80.80%

Return on Equity

  • 10 Years:: 20.56%
  • 5 Years:: 39.34%
  • 3 Years:: 55.06%
  • 1 Year:: 0.47%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019
Share Capital -17171717171717171717171717
Equity Capital16.8616.8616.6016.6016.6016.6016.6016.6016.6016.6016.6016.60
Reserves4064354513303934675065385756477171,524800
Borrowings0000000000000
Other Liabilities -671091018490111125154192215258219250
Trade Payables20403554273836426573809187
Advance from Customers000033465442
Other liability items47696629607085106123138173126162
Total Liabilities4905615684305005946487087848799911,7591,067
Fixed Assets -38606349727585110132111115104101
Gross Block117141148154168178197232271144192191
Accumulated Depreciation7980859096103112122140255163
CWIP22120292873091711
Investments23415324202324242442287000
Other Assets -2153454803594054945305476037117971,639954
Inventories36735861113131152177167164158113114
Trade receivables314444566264841051271071236677
Cash Equivalents1171853251431131931881641882792781,243568
Loans n Advances3247581007453373964771551298
Other asset items-1-3-4-24353706257838486187
Total Assets4905615684305005946487087848799911,7591,067

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018
Cash from Operating Activity -38442661954058310754-130
Profit from operations82707899771099188100130160224
Receivables-3-14-0-13-6-4-21-22-2514-15-30
Inventory-0-3713-2-53-21-23-269-26-28
Payables229-122330002210927
Loans Advances0-8-5-229-5-9-12-2000
Interest paid011100000000
Direct taxes-43-38-32-39-30-40-40-34-32-53-60-304
Other operating items0000015310118-47-20
Cash from Investing Activity -21162176-9-82711-68-75-481,270
Fixed assets purchased-7-29-10-9-15-14-33-40-45-32-30-27
Fixed assets sold020000000000
Investments purchased-1,659-1,485-829-954-567-732-855-911-9900-420
Investments sold1,6741,56795895856473185491297214071
Interest received131721221413181714141717
Dividends received10132122222234
Other investing items-9-68-142158-7-832131-21-7451,204
Cash from Financing Activity --58-20-45-222-00-5-17-12-15-22-30
Dividends paid-50.40-16.82-29.46-189.940.000.00-4.15-14.22-9.93-12.45-18.26-24.90
Other financing items-7.10-2.87-15.75-32.00-0.020.00-0.67-2.40-1.99-2.53-3.72-5.15
Net Cash Flow2-0-22010-283-1417-161,109

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018
ROCE %24%21%21%24%25%26%18%12%15%18%16%78%
Debtor Days364234403834384449396428
Inventory Turnover8.657.097.208.516.775.635.645.275.466.004.346.26

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Procter Gamble Health Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.